Wells Fargo
ARLZ

Wells Fargo’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Wells Fargo’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-805,912
Closed -$282K – 6842
2018
Q2 		$282K Sell
805,912
-212,819
-21% -$175K ﹤0.01% 4843
2018
Q1 		$1.53M Buy
1,018,731
+331,800
+48% +$579K ﹤0.01% 3589
2017
Q4 		$975K Buy
686,931
+413,801
+152% +$679K ﹤0.01% 3953
2017
Q3 		$625K Buy
273,130
+113,720
+71% +$152K ﹤0.01% 4184
2017
Q2 		$215K Sell
159,410
-53,600
-25% -$77.4K ﹤0.01% 4739
2017
Q1 		$456K Sell
213,010
-95,738
-31% -$360K ﹤0.01% 4308
2016
Q4 		$1.36M Buy
308,748
+47,979
+18% +$228K ﹤0.01% 3471
2016
Q3 		$1.26M Buy
260,769
+22,441
+9% +$102K ﹤0.01% 3313
2016
Q2 		$786K Buy
238,328
+54,858
+30% +$207K ﹤0.01% 3641
2016
Q1 		$652K Buy
+183,470
New +$946K ﹤0.01% 3701

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Wells Fargo's ARLZ Position: Q3 2018 in Review

Wells Fargo sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 805,912 shares — an estimated $282K sold.

Wells Fargo first reported a position in ARLZ in Q1 2016 and held it in 10 quarters. The position peaked at $1.53M in Q1 2018. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • Wells Fargo reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Wells Fargo sold 805,912 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $282K.
  • Wells Fargo first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 10 quarters.
  • Wells Fargo's Aralez Pharmaceuticals Inc. position peaked at $1.53M in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Wells Fargo's 13F filing for Q3 2018, filed 2 Nov 2018.